Empower Pharmacy
Empower Clinic Services, LLC (also trading as Empower Pharma) · Houston, TX
We do not sell medication and we have no commercial relationship with Empower Pharmacy. Everything below is either published by a regulator or published by the pharmacy about itself, labelled as such and dated. We give you the official lookups rather than asking you to take our word for the current position.
The short answer
- Empower Pharmacy is the trading name of Empower Clinic Services, LLC (also trading as Empower Pharma), based in Houston, TX. Regulators file under the legal name, so search that.
- Registration: 503A and 503B. Empower runs both a 503A compounding pharmacy and a 503B outsourcing facility, and says so on its own site. FDA records that it registered as an outsourcing facility under section 503B on 16 July 2016, most recently renewing on 6 December 2024. The 503B side is subject to FDA cGMP requirements and direct FDA inspection; the 503A side is not.
- FDA warning letters: 613792 (October 15, 2021), 700962 (April 2, 2025). Read the dates and which site each one covers — both are material.
- Compounded semaglutide and tirzepatide are NOT FDA-approved as finished products, whichever pharmacy prepares them. FDA does not review them for safety, effectiveness or manufacturing quality.
Registration and licence
Empower runs both a 503A compounding pharmacy and a 503B outsourcing facility, and says so on its own site. FDA records that it registered as an outsourcing facility under section 503B on 16 July 2016, most recently renewing on 6 December 2024. The 503B side is subject to FDA cGMP requirements and direct FDA inspection; the 503A side is not.
Accreditation the pharmacy claims
- PCAB standards — Empower states its processes are aligned with cGMP and PCAB standards
We report this as the pharmacy's own statement. We have not independently confirmed it, and we are not endorsing it.
Regulatory record
Every item below is a public document, linked to its source, with the date it was issued and the dates of any inspection behind it. Where the agency recorded the company's response, a completed recall, or which legal entity a record actually concerns, that is included — leaving it out would misrepresent the record. Where the company has answered publicly, its answer is printed too.
- FDA warning letter700962
From an inspection running 2024-08-01 to 2024-08-28.
FDA found products that failed the conditions of section 503B — for example Pyridoxine HCl injection whose container lacked the MedWatch adverse-event details and directions for use — and recorded serious deficiencies in practices for producing drug products intended to be sterile.
Context FDA published with it: FDA acknowledges the firm’s responses dated 19 September 2024 and 31 January 2025, and its recall of Pyridoxine HCl Injection Solution 100 mg/mL, lot 609763, on 5 September 2024.
Our check on July 29, 2026 did not surface a published close-out. That means we did not find one, not that none exists.
Read it on fda.gov - FDA warning letter613792
From an inspection running 2020-02-12 to 2020-03-06.
FDA found products that did not meet the conditions of section 503B: container labelling missing the MedWatch adverse-event reporting details, incomplete six-monthly product reports to FDA in December 2019 and June 2020, adverse-event reporting procedures FDA considered inadequate, and one product compounded by Empower that was sold by another entity.
Context FDA published with it: FDA acknowledges receipt of the firm’s response dated 27 March 2020.
Our check on July 29, 2026 did not surface a published close-out. That means we did not find one, not that none exists.
Read it on fda.gov
What it compounds for GLP-1 patients
- · Compounded semaglutide
- · Compounded tirzepatide
Compounded semaglutide and tirzepatide are not FDA-approved as finished drug products. FDA does not review them for safety, effectiveness or manufacturing quality before they reach patients. That applies to every compounded GLP-1 regardless of which pharmacy prepares it, and it is a separate question from whether the pharmacy is licensed.
If you would rather not take that trade, the FDA-approved oral products now start at $149/month direct from their manufacturers — see the cheapest routes compared.
Check it yourself
Search under the legal name — Empower Clinic Services, LLC (also trading as Empower Pharma) — not the brand. Regulators file under the legal entity, and searching the trading name alone is how records get missed.
- FDA — Registered Outsourcing Facilities (503B)
The authoritative list of pharmacies registered with the FDA as 503B outsourcing facilities (the higher-oversight compounding tier). If a pharmacy claims to be 503B, it should appear here.
- FDA — 503A vs 503B explainer
What the two compounding categories mean: 503A = patient-specific prescriptions under state board oversight; 503B = larger-batch outsourcing facilities under direct FDA cGMP inspection.
- FDA — Warning Letters search
Search the FDA’s public warning-letter database by company name to see whether a pharmacy has an open compliance action. Confirm the date and status — letters can be resolved.
- NABP — Verify a pharmacy / .pharmacy
The National Association of Boards of Pharmacy tools flag rogue online pharmacies and list accredited ones. Legitimate US pharmacies are licensed by a state board.
- LegitScript — Certification lookup
LegitScript certifies healthcare merchants that meet legal + safety standards. Many reputable telehealth GLP-1 providers display a LegitScript badge you can verify here.
- Your state Board of Pharmacy
Every US pharmacy must be licensed by the state board where it operates (and often where it ships). State boards publish license status + disciplinary history.
Questions people ask about Empower Pharmacy
Is Empower Pharmacy a licensed pharmacy?
We have not been able to verify a published state licence record for Empower Pharmacy. Use your state board of pharmacy's lookup to check before buying.
What is the regulatory record for Empower Pharmacy?
FDA issued warning letter 613792 on October 15, 2021, following an inspection running 2020-02-12 to 2020-03-06. FDA found products that did not meet the conditions of section 503B: container labelling missing the MedWatch adverse-event reporting details, incomplete six-monthly product reports to FDA in December 2019 and June 2020, adverse-event reporting procedures FDA considered inadequate, and one product compounded by Empower that was sold by another entity. FDA acknowledges receipt of the firm’s response dated 27 March 2020. FDA issued warning letter 700962 on April 2, 2025, following an inspection running 2024-08-01 to 2024-08-28. FDA found products that failed the conditions of section 503B — for example Pyridoxine HCl injection whose container lacked the MedWatch adverse-event details and directions for use — and recorded serious deficiencies in practices for producing drug products intended to be sterile. FDA acknowledges the firm’s responses dated 19 September 2024 and 31 January 2025, and its recall of Pyridoxine HCl Injection Solution 100 mg/mL, lot 609763, on 5 September 2024. Our check on July 29, 2026 did not surface a published close-out letter, which means we did not find one — not that none exists.
Does Empower Pharmacy make FDA-approved GLP-1 medication?
No compounding pharmacy does. Empower Pharmacy publicly compounds compounded semaglutide and compounded tirzepatide. Compounded drugs are not FDA-approved: the agency does not review them for safety, effectiveness or manufacturing quality before they reach patients. That is true of every compounded product regardless of which pharmacy prepares it, and it is a different thing from the pharmacy being licensed or unlicensed.
How do I check Empower Pharmacy myself?
Three free lookups settle it: the FDA warning-letter database, searched by the legal name (Empower Clinic Services, LLC (also trading as Empower Pharma)) rather than the trading name; the FDA list of registered 503B outsourcing facilities, if the pharmacy claims 503B status; and your state board of pharmacy's licence verification. All three are linked at the bottom of this page. Check the legal name — regulators file under it, and searching the brand alone misses records.